Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-25-118116
Filing Date
2025-12-03
Accepted
2025-12-03 16:00:29
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 tm2532622-1_424b5.htm 424B5 177636
2 GRAPHIC tm2532622d1_424b5img01.jpg GRAPHIC 2892
3 GRAPHIC tm2532622d1_424b5img02.jpg GRAPHIC 36533
  Complete submission text file 0001104659-25-118116.txt   233603
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Theriva Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

EIN.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-291381 | Film No.: 251546376
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)